ECM
AZN icon

ETrade Capital Management’s AstraZeneca AZN Stock Holding History

ETrade Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$4.12M Sell
37,595
-6,093
-14% -$678K 0.08% 132
2020
Q2 		$4.62M Buy
43,688
+21,626
+98% +$2.23M 0.1% 106
2020
Q1 		$1.97M Sell
22,062
-3,463
-14% -$326K 0.05% 196
2019
Q4 		$2.54M Buy
25,525
+1,569
+7% +$148K 0.06% 186
2019
Q3 		$2.13M Buy
23,956
+77
+0.3% +$6.68K 0.05% 207
2019
Q2 		$1.97M Sell
23,879
-12,208
-34% -$957K 0.05% 212
2019
Q1 		$2.92M Sell
36,087
-15,609
-30% -$1.23M 0.08% 140
2018
Q4 		$3.93M Sell
51,696
-5,933
-10% -$463K 0.13% 85
2018
Q3 		$4.56M Buy
57,629
+6,972
+14% +$527K 0.13% 88
2018
Q2 		$3.56M Sell
50,657
-4,484
-8% -$323K 0.11% 104
2018
Q1 		$3.86M Sell
55,141
-4,451
-7% -$308K 0.12% 88
2017
Q4 		$4.14M Buy
59,592
+1,555
+3% +$105K 0.13% 86
2017
Q3 		$3.93M Buy
58,037
+15,218
+36% +$961K 0.14% 79
2017
Q2 		$2.92M Buy
42,819
+32
+0.1% +$2.09K 0.11% 98
2017
Q1 		$2.67M Buy
42,787
+14,944
+54% +$870K 0.11% 108
2016
Q4 		$1.52M Sell
27,843
-5,628
-17% -$320K 0.07% 162
2016
Q3 		$2.2M Buy
33,471
+22,910
+217% +$1.5M 0.11% 120
2016
Q2 		$638K Buy
10,561
+3,831
+57% +$223K 0.03% 297
2016
Q1 		$379K Buy
6,730
+2,598
+63% +$156K 0.02% 352
2015
Q4 		$281K Buy
+4,132
New +$271K 0.02% 387
2014
Q2 		– Sell
-2,483
Closed -$161K – 451
2014
Q1 		$161K Sell
2,483
-9
-0.4% -$581 0.01% 350
2013
Q4 		$148K Sell
2,492
-656
-21% -$35.6K 0.01% 317
2013
Q3 		$163K Buy
3,148
+1,148
+57% +$57.7K 0.02% 282
2013
Q2 		$95K Buy
+2,000
New +$102K 0.01% 321

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ETrade Capital Management's AZN Position: Q3 2020 in Review

ETrade Capital Management reduced its AstraZeneca (AZN) stake by 14% in Q3 2020, selling an estimated $678K and leaving 37,595 shares worth $4.12M. The position accounts for 0.08% of the portfolio, ranked #132.

ETrade Capital Management first reported a position in AZN in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.62M in Q2 2020. 723 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

  • ETrade Capital Management held 37,595 shares of AstraZeneca worth $4.12M as of Q3 2020.
  • ETrade Capital Management sold 6,093 AstraZeneca shares in Q3 2020, an estimated $678K.
  • AstraZeneca made up 0.08% of ETrade Capital Management's portfolio in Q3 2020, its #132 holding.
  • ETrade Capital Management first reported a position in AstraZeneca in Q2 2013 and has held it in 24 quarters since.
  • ETrade Capital Management's AstraZeneca position peaked at $4.62M in Q2 2020.
  • 723 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.